Variability of hepatitis C virus hypervariable region 1 (HVR-1) during the early phase of pegylated interferon and ribavirin therapy
✍ Scribed by Caraballo, Cortés K; Laskus, T; Bukowska-Ośko, I; Pawełczyk, A; Berak, H; Horban, A; Fic, M; Radkowski, M
- Book ID
- 122214974
- Publisher
- Versita
- Year
- 2012
- Tongue
- English
- Weight
- 730 KB
- Volume
- 57
- Category
- Article
- ISSN
- 1896-1126
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Hepatitis C virus (HCV) genotype 1b comprises mainly two subtypes in Japan, each named for its geographic prevalence (Japan‐specific, J type; worldwide, W type). Because the newly identified subtypes have not been fully characterized, the present study directed this issue from virologic
Anemia may increase the likelihood of achieving a sustained virological response (SVR) during pegylated interferon and ribavirin treatment of hepatitis C virus (HCV) infection. To determine whether hemoglobin decline is associated with SVR, we retrospectively evaluated the CHARIOT study of 871 treat